Valiant Laboratories will hold its fifth Annual General Meeting on September 28, 2026. The event is scheduled for 11:30 am and will be conducted via Video Conferencing or Other Audio Visual Means.

The company notified the BSE and NSE on August 31, 2026, regarding the meeting logistics. Shareholders will receive the Notice of AGM and the Annual Report for FY26 only through electronic mode if they have registered email addresses with the company or depositories.

Meeting Logistics

Valiant Laboratories published advertisements in Financial Express and Mumbai Lakshdeep to inform members about the upcoming gathering. The notice is also available on the company’s website and the stock exchange portals.

Members holding shares in physical mode who have not registered their email addresses are requested to submit KYC forms to MUFG Intime India Private Limited. Those holding demat shares should update their details with their Depository Participants.

Voting Procedures

The company has engaged National Securities Depository Limited to facilitate remote e-voting. Shareholders can cast their votes on all resolutions set out in the Notice of the AGM either remotely or during the meeting itself.

Queries regarding the voting process can be directed to NSDL at evoting@nsdl.co.in . Members are advised to review the notes in the AGM notice carefully before participating.

Valiant Laboratories reported a standalone net profit of ₹9.48 crore for the quarter ended June 30, 2026, a 422% increase from ₹1.82 crore in the corresponding period of FY25. The Mumbai-based pharmaceutical company also saw its revenue from operations surge 44% year-on-year to ₹74.27 crore, up from ₹51.68 crore in Q1FY26. Consolidated net profit turned positive at ₹21.10 crore, reversing a loss of ₹3.27 crore recorded in the prior year quarter.

The results were reviewed by the Audit Committee and approved by the Board of Directors in a meeting held on August 10, 2026. The financial statements were prepared in accordance with Indian Accounting Standards (IndAS) prescribed under Section 133 of the Companies Act, 2013, and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company published these audited results in Financial Express and Mumbai Lakshadeep on August 12, 2026, as required under Regulation 30 and Regulation 47 of SEBI LODR.

Financial Performance

Standalone earnings per share (EPS) stood at ₹1.75 for the quarter, compared to ₹0.42 in Q1FY26. On a consolidated basis, EPS was ₹3.89, improving from ₹0.42 in the previous year. The company’s paid-up equity share capital remained unchanged at ₹54.31 crore.

What the Numbers Show

The divergence between standalone and consolidated performance highlights significant operational leverage in the group structure. While standalone net profit before tax grew five-fold to ₹12.73 crore, consolidated pre-tax profit surged more than ten-fold to ₹26.19 crore. This suggests that subsidiaries or associates contributed disproportionately to the top-line growth, which rose 145% on a consolidated basis compared to 44% standalone. The reversal of consolidated losses into a substantial profit indicates improved efficiency or scale benefits across the group entities during the quarter.